Postoperative radiation therapy for endometrial cancer: Where do we go from here?

Practical Radiation Oncology

Volumn 4, Issue 3, 2014, Pages 145-146

  Edelson, Mitchell I ^a   Chen, Lee May ^b   Burke, William M ^c  

^a ABINGTON MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CANCER; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; NOTE; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROGRESSION FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; ONCOLOGY; STANDARDS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; POSTOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC; RADIATION ONCOLOGY;

EID: 84898805318     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.03.011     Document Type: Editorial

References (5)

1. Klopp A., Smith B.D., Alektiar K., Cabrera A., et al. The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2014, 4:137-144.
2. Onsrud M., Cvancarova M., Hellebust T.P., Tropé C.G., Kristensen G.B., Lindemann K. Long-term outcomes after pelvic radiation for early-stage endometrial cancer. J Clin Oncol 2013, 31:3951-3956.
3. Creutzberg C.L., Nout R.A., Lybeert M.L., et al. Fifteen year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys 2011, 81:e631-e638.
4. Baack Kukreja JE, Scosyrev E, Brasacchio RA, Toy EP, Messing EM, Wu G. Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer. BJU Int. doi:10.1111/bju.12543.
5. Landrum L.M., Nugent E.K., Zuna R.E., et al. Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors. Gynecol Oncol 2014, 132:50-54.